Review Potential benefits of cell therapy in coronary heart disease Dense Vincenzo Grimaldi (BiotechD), Francesco Paolo Mancini (MD, PhD)", Amelia Casamassimi (BiolD)*, lohammed Al-Omran (MD)*, Alberto Zullo (PhD), Teresa Infante (BiolD)*, Claudio Napoli (MD, PhD)*© *Depaman chemi. epic, nd Cena Pal, Bere Rear irri De UOC nmanchertlg, st seb tne Sd Uist apes ep iy Sypris igi yf ain ee ay olf Meine Sau Usvasiy. yadSa i SENGE-Asone Bete ees et ‘Fund So Digests cer SIN) CC Np tty ARTICLE INFO ABSTRACT amy ee feces bene ees bh ns cl seh nn eh ef ea Kccreamadtm2iNy299 rca ha ate (HD eel cin nel of CD ave sages at ene sep Prose an ween cl rhthereonng nour nen eet roa {sc ewes er pst somprgetr el the en ted oe x ‘mental an cial setings of cardiac repeneation from embryonic stem elt inde larpotent ere ‘ence Ten we pee conte den the scree segs ec ‘nara of nie oe se egies emt aN ae ‘Sates cute ctesmnghe ene! sre tie jel med Galldavery region Due to the encouraging results fom precincal models, the auriberof lial tials with cell facies {oncogene mp sre st rahe pied sheen yn sy ef. tpn se il Chit Se sushi ost al essing dk oan. ‘usu gist RD eles nna scone Ingest npn sles e's see mp tus eel a ‘ns al cf ie eel ey ree 203 pn Cleef Crt. they Hever Anise cents Ittion 28 Sm oso. zs nsec = Ralvenaats = sence is Siena ce = Sean. = fests > td pure m ouediedit nn i Epigenetic control of CM differentiation . m * Coespcding thor at: Univesity of ania ia Peta 1, 2100 Seen ay Te: 38 D4 SIO: fa 38024700, Enaladhes mnesostinnsal(e2. Manca). e140) sem mater 02013 pee alee of Catdloy.BliselbyEkeve Agha hip. 201405017